Akari Therapeutics PLC
(STU:CLA1)
€
134.4
(0%)
Market Cap: 235.20 Mil
Enterprise Value: 233.42 Mil
PE Ratio: 9,999.00
PB Ratio: 1.13
GF Score: 32/100 Akari Therapeutics PLC (STU:CLA1) Transcripts
- 1